Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;27(5):259-264.
doi: 10.1016/j.jaapos.2023.07.007. Epub 2023 Sep 16.

Genetic testing for infantile nystagmus syndrome with or without associated findings

Kara M Cavuoto  1 , Gil Binenbaum  2 , Melinda Y Chang  3 , Gena Heidary  4 , David G Morrison  5 , Rupal H Trivedi  6 , Stephen J Kim  7 , Stacy L Pineles  8
Affiliations
Review

Genetic testing for infantile nystagmus syndrome with or without associated findings

Kara M Cavuoto et al. J AAPOS. 2023 Oct.

Abstract

Purpose: To review the published literature assessing the clinical utility of genetic testing in individuals with infantile nystagmus syndrome (INS), defined as binocular conjugate nystagmus and onset prior to 6 months of age, with or without associated findings.

Methods: A literature search was last conducted in October 2022. The results were limited to articles published in English. The search yielded 517 abstracts, of which 72 papers were reviewed in full text. Of these papers, 4 met the criteria for inclusion and were graded by a study methodologist.

Results: The 4 studies that met inclusion criteria used next-generation sequencing with gene panels ranging from 31 to 336 genes. The overall molecular diagnostic rate ranged from 35% to 60% in the included studies, although the yield was higher when genetic testing was guided by clinical phenotyping (approximately 80%) and in the subsets of patients with a family history (up to 88%). As many as 30% of patients tested had a reclassification of the diagnosis based on the genetic testing results.

Conclusions: Genetic testing has the potential to provide a definitive diagnosis and identify treatable conditions in patients presenting with INS, especially when considered in conjunction with clinical phenotyping and family history.

PubMed Disclaimer

References

    1. Nash DL, Diehl NN, Mohney BG. Incidence and types of pediatric nystagmus. Am J Ophthalmol 2017;182:31–4. - PMC - PubMed
    1. Hvid K, Nissen KR, Bayat A, Roos L, Grønskov K, Kessel L. Prevalence and causes of infantile nystagmus in a large population-based Danish cohort. Acta Ophthalmol 2020;98:506–13. - PubMed
    1. Bertsch M, Floyd M, Kehoe T, Pfeifer W, Drack AV. The clinical evaluation of infantile nystagmus: what to do first and why. Ophthalmic Genet 2017;38:22–33. - PMC - PubMed
    1. Self JE, Dunn MJ, Erichsen JT, et al. Nystagmus UK Eye research group (NUKE). Management of nystagmus in children: a review of the literature and current practice in UK specialist services. Eye (Lond) 2020;34:1515–34. - PMC - PubMed
    1. U.S. Food and Drug Administration. FDA drug safety communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women. https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-drug-safety-podca.... Accessed July 6, 2023.